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Background: The various prevalence of LVH and abnormal LV geometry have been reported in different
populations. So far, only a few reports are available on the prevalence of LV geometric patterns in a large Chinese
untreated hypertensive population.
Methods: A total of 9,286 subjects (5167 men and 4119 women) completed the survey and 1641 untreated
hypertensive patients (1044 males and 597 females) enrolled in the present study. The LV geometry was classified
into four patterns: normal; abnormal,defined as concentric remodeling;concentric or eccentric hypertrophy based
on the values of left ventricular mass index (LVMI) and relative wall thickness (RWT). Logistic regression model was
applied to determine the odds ratio (OR) and 95% confidence intervals (CI) of the risk factors of left ventricular
hypertrophy.
Results: The prevalence of LVH was 20.2% in untreated hypertensive patients, much higher in women (30.8%) than
in men (14.2%) (P < 0.01). The prevalence of LV geometrical patterns was 34.9%, 11.1%, 9.1% for concentric
remodeling, concentric and eccentric hypertrophy,respectively. After adjustment by using Logistic regression model,
the risk factors for LVH and abnormal LV geometry were age, female, systolic blood pressure, and body mass index.
And low high density lipoprotein maybe a positive factor.
Conclusions: The prevalence of LVH and abnormal LV geometric patterns was higher in women than in men and
increased with age. It is crucial to improve the awareness rate of hypertension and control the risk factors of CV
complications in untreated hypertensive population.
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In hypertensive patients, an adaptive myocardial re-
sponse to increased cardiac afterload results in left ven-
tricular hypertrophy (LVH) [1]. Hypertensive LVH is a
powerful independent predictor for sudden cardiac death
[2], ventricular arrhythmias [3], myocardial ischemia [4],* Correspondence: ganxibaozhongxin@sina.com; huirutai@gmail.com
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unless otherwise stated.coronary heart disease [5], heart failure [6], as well as is-
chemic stroke [7].
Echocardiography is more sensitive and specific than
electrocardiography in the detection of LVH [8]. Classifi-
cation of patients based on whether left ventricular mass
index (LVMI) and relative wall thickness (RWT) are nor-
mal or abnormal yields four left ventricular (LV) geometric
patterns: normal, concentric remodeling, concentric hyper-
trophy and eccentric hypertrophy [9]. Previous studies have
reported that echocardiographically determined LV geom-
etry can independently predict major cardiovascular events
[10], and the worst is concentric hypertrophy, followed by
eccentric hypertrophy, concentric remodeling and normalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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http://www.biomedcentral.com/1471-2261/14/136geometry [11]. In addition, LV geometric pattern is closely
related to stroke risk [12].
The various prevalence of LVH and abnormal LV geom-
etry have been reported in different populations [13,14].
So far, only a few reports are available on the prevalence
of LV geometric patterns in a large Chinese untreated
hypertensive population. Therefore, we conducted a cross-
sectional study to survey the prevalence of LVH and LV




This community-based cross-sectional study was con-
ducted in the Rizhao City and Hong Xing Long County, in
the northern region of China from 2009 to 2010. A multi-
stage cluster sampling method was used. A total of 9,286
subjects (5167 men and 4119 women) completed the
survey, yielding a response rate of 97.48%. Among them,
2984 hypertensive patients were identified and thoroughly
examined. Hypertension was defined as diastolic blood
pressure (DBP) of ≥90 mmHg, and/or systolic blood pres-
sure (SBP) of ≥140 mmHg, physician diagnosis, or current
medication for hypertension (as defined by WHO 1999).
Untreated hypertension was defined as never receiving
any antihypertensive treatment befor the study.
Patients were excluded if they had hypertrophic cardio-
myopathy, ischemic heart disease, congenital heart disease,
or other organic heart disease including valvular disease.
Patients with secondary hypertension, either suspected or
established, were excluded as well.
The study was governed under the most recent
(2007–2008) version of the World Medical Association’s
Declaration of Helsinki. The study protocol was reviewed
and approved by the ethical committees of the Fuwai
Hospital and local hospitals. Participation is voluntary; in-
formed consent was obtained from each participant. All
investigators were trained at the Cardiovascular Institute,
Chinese Academy of Medical Sciences (Beijing, China)
and qualified for the clinical investigation.
Data collection
We identified eligible individuals according to their age
and documents of residence and invited them to a com-
munity clinic by telephone. Each participant was inter-
viewed and completed a standardized questionnaire that
included a range of demographic factors, medical his-
tory, history of medications, and lifestyle.
Physical examination
Anthropometric measurements of subjects who wore
light clothing and were in bare feet were conducted by
experienced research staff. Height was measured once tothe nearest 0.1 cm, and weight was measured in the up-
right position to the nearest 0.1 kg.
BP was measured by trained professionals with a stan-
dardized mercury sphygmomanometer, and one of three
cuff sizes (regular adult, large, or small) was chosen on the
basis of the circumference of the participant’s right arm.
All participants were advised to avoid alcohol, cigarette
smoking, coffee/tea, and exercise for at least 30 minutes
before their BP measurement. Three BP readings were re-
corded at least 1 minute apart in the sitting position after
at least 5-minute rest and averaged for further analysis.
Echocardiography
Transthoracic echocardiography was performed accord-
ing to standard protocol [15] with M-mode, 2-
dimensional (2D), and color Doppler recordings from
the parasternal long-axis and short-axis windows, as
well as 2D and color Doppler evaluations from the apical
window to yield 2-, 3-, and 4-chamber images with an HP
5500 (Phillips Medical System, Boston, Massachusetts,
USA). The transducer frequency was 2.5 to 3.5 MHz.
Optigo echocardiographic recorders (Agilent, Boston,
Massachusetts, USA) were used occasionally to screen
subjects who could not reach the local study center.
The echocardiographic examination was supervised by
2 physician-echocardiographers with at least 2 years of
experience. Before the study, they were trained in the
echocardiographic protocol at the Cardiovascular Insti-
tute, Chinese Academy of Medical Sciences.
Calculation of derived variables
Left ventricular mass (LVM) was calculated using the
equation:
LVM = 0.8 × 1.04 × [(IVSd + LVIDD + PWTd)3–
LVIDD3] + 0.6, which yields values closely related (R =
0.90) to necropsy LV weight [16], where IVSd is septal
wall thickness at end diastole, PWTd is posterior wall
thickness at end diastole , and LVIDD is left ventricular
end-diastolic diameter.
LVM was divided by height2.7 and body surface area
(BSA) to obtain left ventricular mass index (LVMIh2.7 and
LVMIBSA). BSA was calculated by using the Du Bois formula
[17]: 0.0 071 843 × (weight (kg))0.4253 × (height (cm))0.725.
LV hypertrophy was diagnosed by using the criteria of
the LVMIh2.7 more than 49.2 g/m
2.7 and 46.7 g/m2.7 for
males and females, respectively [18]. Relative wall thick-
ness (RWT) [19] was calculated by 2 × PWTd/LVIDD.
The LV geometry was classified into four patterns based
on LVMI and RWT [20] values:
(1) Normal geometry: LVMI was normal and RWT
was < 0.43;
(2) Concentric hypertrophy: LVMI was increased and
RWT was ≥ 0.43;
Table 1 Clinical characteristics of 1641 untreated hypertensive patients
Variables Whole group (n = 1641) Male (n = 1044) Female (n = 597) p value
Age (years) 50.4 ± 12.18 47.8 ± 12.26 55.1 ± 10.53 <0.001
Height (cm) 165.6 ± 8.76 170.3 ± 6.47 157.5 ± 5.90 <0.001
Weight (kg) 73.5 ± 12.97 78.7 ± 11.76 65.6 ± 9.75 <0.001
BMI (kg/m2) 26.7 ± 3.38 27.1 ± 3.28 26.0 ± 3.50 <0.001
BSA (m2) 1.8 ± 0.19 1.9 ± 0.16 1.7 ± 0.13 <0.001
SBP (mmHg) 139.5 ± 15.29 138.8 ± 14.69 140.7 ± 16.23 0.013
DBP (mmHg) 92.0 ± 9.34 93.7 ± 8.83 88.9 ± 9.43 <0.001
PP(mmHg) 47.5 ± 15.52 45.1 ± 14.19 51.8 ± 16.79 <0.001
MAP (mmHg) 107.8 ± 9.09 108.7 ± 8.90 106.2 ± 9.19 <0.001
Plasma glucose (mmol/L) 5.5 ± 1.86 5.4 ± 1.98 5.7 ± 1.59 <0.001
Cholesterol (mmol/L) 5.4 ± 1.05 5.5 ± 1.05 5.3 ± 1.03 0.017
Triglyceride (mmol/L) 2.0 ± 1.54 2.2 ± 1.78 1.7 ± 0.97 <0.001
High density lipoprotein (mmol/L) 1.5 ± 0.36 1.4 ± 0.37 1.5 ± 0.35 <0.001
Low density lipoprotein (mmol/L) 3.0 ± 1.02 3.0 ± 1.08 3.0 ± 0.91 0.727
Diabetes (%) 94(5.7) 46(4.4) 48(8.1) 0.003
Obesity (%) 252(15.4) 176(16.9) 76(12.7) 0.027
BMI = Body Mass Index, BSA = Body Surface Area, SBP = Systolic Blood Pressure, DBP = Diastolic Blood, PP = Pulse Pressure, MAP =Mean Arterial Blood Pressure.
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RWT was < 0.43;
(4) Concentric remodeling: LVMI was normal and
RWT was ≥ 0.43.
Statistical analysis
Data are reported as mean ± standard deviation (SD) for
continuous variables and as frequency for categorical vari-
ables. Differences in continuous variables between two
groups were compared with a Student t-test and differences
in categorical variables were measured with a chi-square
test. Differences between multiple groups were performed
by analysis of variance (ANOVA). Logistic regression was
used to calculate odds ratios (ORs) and their 95% confi-
dence intervals (CIs). Potential confounders were adjusted.
A 2-tailed value of P < 0.05 was considered significant. Ana-
lyses were performed with SPSS 11.0 (SPSS Inc, Chicago,
USA) for Windows (Microsoft Corp, Redmond, USA). TheTable 2 Echocardiographic characteristics of 1641 untreated
Variables Whole group (n = 1641)
IVSd (mm) 10.6 ± 2.14
PWTd (mm) 9.4 ± 1.54
LVIDD (mm) 44.4 ± 5.25
LV mass(g) 152.5 ± 46.43
LVMI-BSA(g/m2) 84.5 ± 24.70
LVMI-height2.7(g/m2.7) 39.4 ± 12.60
RWT(cm) 0.43 ± 0.092
IVSd: end-diastolic interventricular septal thickness; PWTd: end-diastolic posterior wall t
index divided by body mass index; LVMIh2.7: left ventricular mass index divided by heigauthors had full access to the data and take full responsibil-
ity for its integrity.Results
Clinical and echocardiographic characteristics of
untreated hypertensive population
A total of 1641 untreated hypertensive patients (1044
males and 597 females) with integrated clinical and echo-
cardiographic data enrolled in the present study (Table 1
and Table 2).
LVIDD as well as PWTd were larger in men than in
women, so did LV mass (158.1 ± 48.04 g vs. 142.5 ±
41.69 g, P <0.001). The trend was opposite after indexed
by height2.7 (37.8 ± 12.24 vs. 42.0 ± 12.79, P <0.001), and
by BSA (83.5 ± 25.13 vs. 86.2 ± 23.84, P =0.027). More-
over, RWT was higher in women, but this difference did
not attain statistical significance.hypertensive patients
Male (n = 1044) Female (n = 597) p value
10.5 ± 2.20 10.7 ± 2.03 0.053
9.5 ± 1.46 9.1 ± 1.64 <0.001
45.3 ± 4.97 42.9 ± 5.37 <0.001
158.1 ± 48.04 142.5 ± 41.69 <0.001
83.5 ± 25.13 86.2 ± 23.84 0.027
37.8 ± 12.24 42.0 ± 12.79 <0.001
0.43 ± 0.085 0.44 ± 0.102 0.117
hickness; LVIDD: end-diastolic LV internal dimension; LVMIBSA: left ventricular mass
ht2.7; RWT: relative wall thickness.
Figure 1 Prevalence of left ventricular hypertrophy (LVH) in
different age and sex groups. The prevalence was much higher in
women than in men in the age groups of 45–60 and ≥60 (p < 0.01),
and increasing with ageing.
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Of 1641 untreated hypertensive patients, 20.2% (n = 332)
was found to be LVH, 14.2% in men and 30.8% in
women respectively. Sex-specific prevalence of LVH in-
creased with ageing (Figure 1).The distribution of LV geometric patterns
The total distribution of LV geometric patterns was con-
centric hypertrophy (11.1%), eccentric hypertrophy (9.1%),
concentric remodeling (34.9%) and normal geometric
(44.9%). Concentric remodeling was the most common
abnormal LV geometric pattern in men (35.9%), also, in
women (33.0%). The LV geometric abnormality increased
steadily with ageing (from 43.8% to 71.0%) (Table 3).The risk factors of LVH in untreated hypertensive patients
After adjusted for age, sex, systolic blood pressure, dia-
stolic blood pressure, body mass index, cholesterol, trigly-
ceride, high density lipoprotein cholesterol, low density
lipoprotein cholesterol, smoking history, drinking his-














Total 737(44.9) 572(34.9)identified by using Logistic regression model for con-
founders: age, female, SBP, BMI (Table 4).
The risk factors of abnormal LV geometric patterns in
untreated hypertensive patients
After adjusted for age, sex, systolic blood pressure, dia-
stolic blood pressure, body mass index, cholesterol, trigly-
ceride, high density lipoprotein cholesterol, low density
lipoprotein cholesterol, smoking history, drinking history,
history of diabetes by using Logistic regression model for
confounders, the risk factor of concentric remodeling was
only age. The risk factors of concentric hypertrophy were
age, female, SBP, BMI. The risk factors of eccentric hyper-
trophy were age, female, SBP, BMI, and high density lipo-
protein and drinking history was found as protective
factors for eccentric hypertrophy (Table 5).
Discussion
In the present study, the prevalence of LVH was 20.2% in
the untreated hypertensive patients, while the prevalence
of echocardiographic LVH was 42.8% among community-
based hypertensive population previously reported by our
group [21]. In other studies, the prevalence of LVH in un-
treated hypertensive cohorts was quite different, from 19%
to 48% [18,22,23]. The distribution of abnormal LV geo-
metric patterns was 34.9%, 11.1% and 9.1% for concentric
remodeling, concentric hypertrophy and eccentric hyper-
trophy in this study, respectively, while our group found
the distribution was shown to be 24.7%, 22.6%, 20.2% re-
spectively in hypertensive patients [21]. Concentric remod-
eling was the most prevalent type of abnormal LV geometry
in both sexes. Concentric hypertrophy, a LV geometric pat-
tern related to a worse CV prognosis [24,25], was more
prevalent than eccentric hypertrophy , while lots of studies
had come to the opposite conclusion [26-30]. The variation
might result from the differences in age, gender, geograph-
ical region, diagnostic criteria, and risk factors.
It is worth noting that female was strongly associated












Table 4 The risk factors of LVH
Variables Odds ratio 95% CI P
Age,year 1.06 1.05-1.07 <0.001
Sex (0 =male,1 = female) 1.94 1.38-2.74 <0.001
SBP,mmHg 1.02 1.01-1.03 <0.001
BMI, kg/m2 1.19 1.14-1.24 <0.001
Cholesterol, mmol/L 0.876 0.759-1.010 0.069
HDL, mmol/L 0.66 0.42-1.05 0.079
Drinking history (0 = no,1 = yes) 0.69 0.47-1.02 0.060
Odds ratio was relative to no LVH. Adjusted for age, sex, systolic blood
pressure, diastolic blood pressure, body mass index, cholesterol, triglyceride,
high density lipoprotein cholesterol, low density lipoprotein cholesterol,
smoking history, drinking history, history of diabetes. P value for variables to
enter or stay in the model was set at <0.10. CI, confidential interval.
Li et al. BMC Cardiovascular Disorders 2014, 14:136 Page 5 of 7
http://www.biomedcentral.com/1471-2261/14/136in this study. This is in line with the majority of reports
[31,32], as well as our previous study [21].
Ageing was also related with increased prevalence of
LVH and abnormal LV geometry in untreated patients.
These data were in line with our previous study [21]. De
Simone et al. [33]. Have also reported that, in both
normotensive and hypertensive patients, left ventricle
mass steadily increases with age. The Bogalusa Heart
Study indicates that age-related increase in left ventricu-
lar mass could be partially interpreted by changes in
body size and in BP [34]. Due to the aging of general
population in China, it demonstrated that the incidence
of LVH would increase. Also, both SBP and BMI were
associated with LVH after adjusted for other risk factors,
consistented with the result of published studies [32,35].
Furthermore, a further aspect of our study was that
maybe low high density lipoprotein was associated with
higher prevalence of eccentric hypertrophy after adjusted
for other risk factors.
The advantages of the study is that, this is a good
community-based survey design, the routine ascertain-
ment of LVH, and the definition of risk factors, surveyTable 5 The risk factors of abnormal left ventricular geometr
Variables Concentric remodeling
Odds ratio 95% CI P
Age,year 1.02 1.01-1.03 <0.001
Sex
(0 =male,1 = female) 1.20 0.93-1.55 0.158
SBP,mmHg 1.00 0.99-1.01 0.615
BMI, kg/m2 0.99 0.95-1.03 0.567
HDL, mmol/L 0.92 0.64-1.31 0.651
Drinking history (0 = no,1 = yes) 1.00 0.75-1.33 0.974
Odds ratio was relative to normal geometry pattern. Adjusted for age, sex, systolic
triglyceride, high density lipoprotein, low density lipoprotein, smoking history, drink
model was set at <0.10. CI, confidential interval.data and echocardiography, which are similar to other
well-known community-based studies.
In addition, another aspect of the present study de-
serves to be briefly discussed. A remarkable portion of
untreated hypertensive patients enrolled in this study
have had the manifestation of cardiac damage such as
LVH, this suggests that primary prevention of cardiovas-
cular disease is extremely crucial and claims for raising
awareness of hypertensive status and controling risk fac-
tors for cardiovascular disease.
Several limitations applied to our study. First, our find-
ings are not fully applicable to Han Chinese, as our samples
comprised untreated hypertensive residents in the northern
region of China. Second, the cross-sectional nature of this
study limits the prediction of abnormal LV geometric pat-
terns on cardiovascular and cerebrovascular events, which
should be confirmed with a prospective study.
Conclusions
Our study indicates that, in untreated hypertensive patients,
LVH and abnormal LV geometric patterns is a predilection
for female and the prevalence of LVH and abnormal LV
geometric patterns increased with age.
Age, female, SBP, BMI are the major risk factors for
LVH and abnormal LV geometric patterns. Also, low high
density lipoprotein maybe has a positive effect on LVH.
Even though improved diagnosis and treatment of hy-
pertension recent years, primary prevention of cardiovas-
cular (CV) disease is extremely crucial. To effectively
reducing of CV complications, it is of utmost importance
that not only weight and BP control but also improving
the awareness rate of hypertension in China and the risk
factors of CV complications.
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